Idexx Laboratories (IDXX) Free Cash Flow (2009 - 2026)

Idexx Laboratories' Free Cash Flow history runs 18 years deep, the most recent figure standing at $234.3 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 3.08% year-over-year to $234.3 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 22.73% YoY), while the FY2025 annual figure was $1.1 billion, up 30.82% from the prior year.
• Free Cash Flow for Q1 2026 stood at $234.3 million, down from $326.3 million in the prior quarter.
• The five-year high for Free Cash Flow was $326.3 million in Q4 2025, with the low at $44.3 million in Q4 2022.
• The 5-year median for Free Cash Flow is $192.0 million (2024), against an average of $192.1 million.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow tumbled 75.16% in 2022, then jumped 391.05% in 2023.
• Idexx Laboratories' Free Cash Flow stood at $44.3 million in 2022, then surged by 391.05% to $217.3 million in 2023, then rose by 7.12% to $232.8 million in 2024, then soared by 40.19% to $326.3 million in 2025, then decreased by 28.21% to $234.3 million in 2026.
• Business Quant data shows IDXX's Free Cash Flow at $234.3 million in Q1 2026, $326.3 million in Q4 2025, and $315.6 million in Q3 2025.